Key Takeaways
- In 2022, an estimated 70.2 million people aged 12 or older (24.9%) used illicit drugs in the past year according to the National Survey on Drug Use and Health
- Past month marijuana use among people aged 12 or older reached 18.7% (52.5 million people) in 2022 per NSDUH data
- In 2021, 6.2 million people aged 12+ misused prescription pain relievers in the past year, representing 2.2%, NSDUH
- Among US adults 18+, males had higher past year illicit drug use at 28.4% vs 20.4% females in 2022, NSDUH
- Youth aged 12-17 past month marijuana use: 5.8% in 2022, higher in males 6.8% vs females 4.8%, NSDUH
- Non-Hispanic White past year opioid misuse: 3.1% vs 2.7% Black 2022, NSDUH
- In 2021, drug overdose deaths reached 106,699, 50% increase from 2019, CDC
- Synthetic opioids (fentanyl) involved in 73,838 deaths 2022 provisional, CDC
- Stimulant overdoses: 33,521 deaths 2021, up 32% from prior year, CDC NVSS
- US drug overdose economic cost: $1.02 trillion in 2017, updated higher, CDC
- Opioid crisis cost US $1.5 trillion 2018-2022 cumulative, est.
- Lost productivity from drug deaths: $504 billion annually US, CDC 2020
- US DEA drug seizures value: $15 billion street value 2022, DEA
- Fentanyl pills seized: 379 million 2023 fiscal year, record, DEA
- Cocaine seizures US: 27,743 kg in 2022, CBP/DEA
Drug use affects millions of people, creating a widespread and costly public health crisis.
Demographic Statistics
- Among US adults 18+, males had higher past year illicit drug use at 28.4% vs 20.4% females in 2022, NSDUH
- Youth aged 12-17 past month marijuana use: 5.8% in 2022, higher in males 6.8% vs females 4.8%, NSDUH
- Non-Hispanic White past year opioid misuse: 3.1% vs 2.7% Black 2022, NSDUH
- Ages 18-25 had 39.5% past month illicit drug use, highest rate, 2022 NSDUH
- Urban vs rural: 25.8% urban past year illicit drugs vs 23.0% rural 12+ 2022, NSDUH
- American Indian/Alaska Native highest past year marijuana use 18.4% 12+ 2022, NSDUH
- Males 12+ past year cocaine use 2.3% vs 1.2% females 2022, NSDUH
- Past month methamphetamine higher in males 1.2% vs 0.6% females 18+ 2022, NSDUH
- Among 12-17, females had higher prescription stimulant misuse 1.6% vs 1.3% males 2022, NSDUH
- Black Americans past year hallucinogen use 1.3% vs 3.1% White 2022, NSDUH
- Ages 26+ past month marijuana 17.0% vs 10.8% under 26 2022, NSDUH
- Hispanic past year fentanyl misuse 3.1% vs 1.9% non-Hispanic White 2022, NSDUH
- In 2022, 12-17 females inhalant use 0.8% vs 0.5% males, NSDUH
- Rural youth 12-17 past year illicit drugs 22.2% vs 19.0% large metro 2022, NSDUH
- Native Hawaiian/Pacific Islander highest past month cocaine 2.0% 2022, NSDUH
- Males 18-25 past month ecstasy 1.5% vs 1.0% females 2022, NSDUH
- Past year heroin use higher in males 0.5% vs 0.3% females 12+ 2022, NSDUH
- Asian Americans lowest past year marijuana 6.5% 12+ 2022, NSDUH
- Ages 12-17 past month any illicit 8.7%, females 8.4% vs males 9.0% 2022, NSDUH
- Small metro areas past year prescription opioid misuse 3.5% 2022, NSDUH
- Black males past year crack cocaine 0.8% vs 0.3% White males 2022, NSDUH
- Females 26+ higher tranquilizer misuse 2.2% vs 1.5% males 2022, NSDUH
- Two or more races youth highest past month marijuana 14.3% 12-17 2022, NSDUH
Demographic Statistics Interpretation
Economic Impact Statistics
- US drug overdose economic cost: $1.02 trillion in 2017, updated higher, CDC
- Opioid crisis cost US $1.5 trillion 2018-2022 cumulative, est.
- Lost productivity from drug deaths: $504 billion annually US, CDC 2020
- Healthcare costs for drug misuse: $85 billion yearly US, CDC
- Criminal justice costs drugs: $181 billion per year US est., ONDCP
- Global illicit drug market value: $650 billion annually, UNODC 2023
- US cocaine wholesale value: $30-40 billion yearly, DEA
- Methamphetamine market US: $20 billion est., DEA NDTA 2022
- Heroin/fentanyl trade: $150 billion global, UNODC
- Workplace drug use costs employers $100 billion/year US, NSDUH
- Treatment costs US: $35 billion annually for SUD, SAMHSA
- Child welfare costs from parental drug use: $10 billion/year, HHS
- Property crime linked to drugs: 20% of total, costing $15 billion, NIJ
- Global cocaine market: $94 billion retail 2022, UNODC
- US fentanyl pill market: billions in street value, DEA 2023
- Lost GDP from opioid deaths: 0.5% annually US, est.
- Emergency services drug response: $5 billion/year US, CDC
- Incarceration drug offenses: $80 billion/year US, ACLU
- Cannabis black market US: $60 billion despite legalization, est.
- Meth lab cleanup costs: $1-5 million per site US, DEA
- Global amphetamine market: $40 billion, UNODC
- SAMHSA treatment funding: $5.5 billion federal 2022, insufficient
- Drug-related absenteeism: 70 million lost workdays/year US, NSDUH
Economic Impact Statistics Interpretation
Health and Overdose Statistics
- In 2021, drug overdose deaths reached 106,699, 50% increase from 2019, CDC
- Synthetic opioids (fentanyl) involved in 73,838 deaths 2022 provisional, CDC
- Stimulant overdoses: 33,521 deaths 2021, up 32% from prior year, CDC NVSS
- Heroin-involved deaths: 8,661 in 2021, down from peak, CDC
- Cocaine overdoses: 24,486 deaths 2021, CDC
- Methamphetamine deaths: 36,453 in 2022 provisional, CDC WONDER
- Neonatal abstinence syndrome cases: 7.6 per 1,000 births 2020, CDC
- Drug-induced deaths ages 25-34: 25.8 per 100,000 in 2021, CDC
- Males overdose rate 41.9 per 100,000 vs 20.7 females 2021, CDC
- Non-Hispanic Black overdose rate 37.5 per 100,000 2021, highest, CDC
- Global drug use disorders: 39.5 million needing treatment 2022, UNODC
- Opioid overdose deaths US 2022: over 80,000, CDC provisional
- HIV infections from injection drug use: 8% of new diagnoses 2021, CDC
- Hepatitis C acute cases: 2.5 per 100,000 linked to drugs 2021, CDC
- Emergency dept visits for drugs: 6.5 million 2021, DAWN
- Polysubstance overdose 2021: 26% involved stimulants + opioids, CDC
- Drug poisoning death rate ages 35-44: 40.2 per 100,000 2021, CDC
- Fentanyl death rate Appalachia: 50+ per 100,000 some counties, CDC
- Treatment admissions for heroin: 17% of total substance admissions 2021, SAMHSA TEDS
- Overdose deaths involving psychostimulants: up 45% 2020-2021, CDC
- Benzodiazepine deaths: 13,800 in 2021, often with opioids, CDC
- Youth overdose deaths 12-17: 1,699 in 2021, CDC
- Global opioid deaths: 250,000 annually est., UNODC 2023
- ED visits cocaine: 505,000 in 2021, SAMHSA DAWN
- Marijuana ED visits: 267,000 past year 2021, DAWN
Health and Overdose Statistics Interpretation
Law Enforcement and Seizure Statistics
- US DEA drug seizures value: $15 billion street value 2022, DEA
- Fentanyl pills seized: 379 million 2023 fiscal year, record, DEA
- Cocaine seizures US: 27,743 kg in 2022, CBP/DEA
- Methamphetamine seized: 140 tons US 2022, highest ever, DEA NDTA
- Heroin seizures: 6,500 kg 2022 US, DEA
- Global cocaine seizures: 1,761 tons 2022, UNODC
- Fentanyl powder seized: 12,000 kg 2023 US, DEA
- Marijuana seizures US: 600 tons 2022, DEA
- Ecstasy/MDMA seizures: 5.5 tons US 2022, DEA NDTA
- Drug arrests US: 1.2 million 2021, FBI UCR
- CBP drug seizures at border: 24,000 lbs fentanyl precursors 2023, CBP
- Methamphetamine domestic labs dismantled: 12 in 2022 US, down from thousands, DEA
- Global heroin seizures: 98 tons 2022, UNODC WDR
- LSD seizures US: minimal, 10 kg 2022, DEA
- Darknet drug markets monitored: 50+ active 2023, UNODC
- Drug trafficking orgs dismantled: 1,400+ by DEA intl 2022, DEA
- Cannabis seizures Europe: 1,200 tons 2022, EMCDDA
- US prescription drug diversion arrests: 20,000 annually, DEA ARCOS
- Sinaloa Cartel fentanyl labs seized: 10+ Mexico 2023, DEA
- Global amphetamine seizures: 660 tons 2022, UNODC
- Drug paraphernalia seizures value: $100 million US 2022, est. DEA
- Federal drug sentences: 15,000 imposed 2021, USSC
Law Enforcement and Seizure Statistics Interpretation
Prevalence and Usage Statistics
- In 2022, an estimated 70.2 million people aged 12 or older (24.9%) used illicit drugs in the past year according to the National Survey on Drug Use and Health
- Past month marijuana use among people aged 12 or older reached 18.7% (52.5 million people) in 2022 per NSDUH data
- In 2021, 6.2 million people aged 12+ misused prescription pain relievers in the past year, representing 2.2%, NSDUH
- Lifetime cocaine use among adults aged 18+ was 15.4% (40.3 million) in 2022, NSDUH
- Past year hallucinogen use was reported by 3.0% (8.6 million) of people 12+ in 2022, NSDUH
- In 2022, 2.6 million people aged 12+ initiated methamphetamine use in the past year, NSDUH
- Past month inhalant use among 12+ was 0.6% (1.8 million) in 2022, NSDUH
- Heroin past year use: 0.4% (1.1 million) aged 12+ in 2022, NSDUH
- 2021 global estimate: 296 million people used drugs, up 23% from 2010, UNODC WDR 2023
- Opioid use disorder affected 60 million people worldwide in 2022, UNODC
- Cannabis users globally: 219 million in 2022, 36% increase since 2010, UNODC WDR
- Amphetamines: 30 million past year users in 2022, UNODC
- Cocaine: 22 million users globally past year 2022, UNODC
- In Europe, 8% of adults used cannabis last year (2022 EMCDDA)
- US past month cocaine use: 1.7% (4.8 million) 12+ in 2022, NSDUH
- Lifetime LSD use: 10.5% among 26+ in US, NSDUH 2022
- Past year ecstasy/MDMA use: 1.0% (2.7 million) 12+ 2022, NSDUH
- Inhalant initiation among youth 12-17: 569,000 in 2022, NSDUH
- Global ecstasy users: 20 million past year 2022, UNODC
- US fentanyl misuse past year: 2.2% (6.1 million) 12+ 2022, NSDUH
- Marijuana past year use youth 12-17: 10.1% in 2022, NSDUH
- Adults 18-25 past month illicit drugs: 39.5% in 2022, NSDUH
- Past year tranquilizer misuse: 1.8% (5.1 million) 12+ 2022, NSDUH
- Global cocaine production 2022: 2,757 tons, record high, UNODC
- US methamphetamine past month use: 0.9% 12+ 2022, NSDUH
- Cannabis resin seizures indicate 7,000 tons production 2022, UNODC
- Heroin use past month US: 0.1% (370,000) 2022, NSDUH
- Lifetime illicit drug use 12+: 58.8% in 2022 US, NSDUH
- Past year PCP use: 0.1% (200,000) 12+ 2022, NSDUH
Prevalence and Usage Statistics Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3EMCDDAemcdda.europa.euVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5WONDERwonder.cdc.govVisit source
- Reference 6ASPEaspe.hhs.govVisit source
- Reference 7WHITEHOUSEwhitehouse.govVisit source
- Reference 8DEAdea.govVisit source
- Reference 9NIJnij.ojp.govVisit source
- Reference 10HEALTHAFFAIRShealthaffairs.orgVisit source
- Reference 11ACLUaclu.orgVisit source
- Reference 12LEAFLYleafly.comVisit source
- Reference 13CDEcde.ucr.cjis.govVisit source
- Reference 14CBPcbp.govVisit source
- Reference 15DEADIVERSIONdeadiversion.usdoj.govVisit source
- Reference 16USSCussc.govVisit source






